Paid Clinical Trials in Bethesda, MD

As of August 2026, 900 paid clinical trials are recruiting in Bethesda, Maryland. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 10, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

803 clinical trials

X-linked Moesin Associated Immunodeficiency

for Immune Deficiency

Sites in Bethesda +2 more locations

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France

Sex: Male·Age: 4 - 80

Code: NCT06278337·Recruiting·Listed Feb 2024

Apply to this trial

Collection of Clinical Data and Specimens for Research in Hearing, Balance, Taste, Smell, Voice, Speech, and Language Disorders.

for Hearing Loss

1 location in Bethesda

Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD)

Sex: All·Age: 2 - 99

Code: NCT05670496·Recruiting·Listed Jan 2023

Apply to this trial

Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS)

for Neck Pain

1 location in Bethesda

Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

Sex: All·Age: 18 - 65

Code: NCT06214949·Recruiting·Listed Jan 2024

Apply to this trial

Investigational Use of Neuromuscular Ultrasound

for Muscular Dystrophy

1 location in Bethesda

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Sex: All·Age: 18 - 110·Accepts healthy volunteers

Code: NCT05237973·Recruiting·Listed Feb 2022

Apply to this trial

Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.

for COVID-19, Long Haul

1 location in Bethesda

Sponsor: Well- Konnect Healthcare Services and Research Firm

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT06441955·Phase 4·Recruiting·Listed Jun 2024

Apply to this trial

Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome

for Overactive Bladder Syndrome

1 location in Bethesda

Sponsor: Walter Reed National Military Medical Center

Sex: Female·Age: 18+·Accepts healthy volunteers

Code: NCT05221021·Phase 4·Recruiting·Listed Feb 2022

Apply to this trial

The PCOS Challenge Study

for Polycystic Ovary Syndrome

1 location in Bethesda

Sponsor: PCOS Challenge: The National Polycystic Ovary Syndrome Association

Sex: Female·Age: 12 - 80·Accepts healthy volunteers

Code: NCT05797909·Recruiting·Listed Apr 2023

Apply to this trial

Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)

for Severe Aplastic Anemia

1 location in Bethesda

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All·Age: 3 - 99

Code: NCT04304820·Phase 2·Recruiting·Listed Mar 2020

Apply to this trial

Study of Gastric Motility in Eosinophilic Gastritis

for Eosinophilic Gastritis

Sites in Bethesda +2 more locations

Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All·Age: 18 - 59

Code: NCT05229432·Recruiting·Listed Feb 2022

Apply to this trial

Characterization of an Optically Pumped Magnetometer (OPM) Magnetoencephalography (MEG) Array

for Normal Physiology

1 location in Bethesda

Sponsor: National Institute of Mental Health (NIMH)

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT04950309·Recruiting·Listed Jul 2021

Apply to this trial

The Effect of Sex Steroid Replacement Therapy in the Hypogonadism and Transgender Active-Duty Population

for Hypogonadism

1 location in Bethesda

Sponsor: Walter Reed National Military Medical Center

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT06247267·Recruiting·Listed Feb 2024

Apply to this trial

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

for Hematologic Malignancy

Sites in Bethesda, Baltimore +27 more locations

Sponsor: Therapeutic Advances in Childhood Leukemia Consortium

Sex: All·Age: 1 - 21

Code: NCT05476770·Phase 1·Recruiting·Listed Jul 2022

Apply to this trial

Spinal Cord Injury Registry - North American Clinical Trials Network

for Spinal Cord Injury

Sites in Bethesda, Baltimore +8 more locations

Sponsor: Robert G. Grossman, MD

Sex: All·Age: 18+

Code: NCT00178724·Recruiting·Listed Sep 2005

Apply to this trial

Nightmare Deconstruction and Reprocessing vs. NightWare Wristband

for Nightmare

1 location in Bethesda

Sponsor: Uniformed Services University of the Health Sciences

Sex: All·Age: 22 - 64

Code: NCT06399874·Phase 2·Recruiting·Listed May 2024

Apply to this trial

Bladder Botox UTI Antibiotic Prophylaxis

for Overactive Bladder

1 location in Bethesda

Sponsor: Walter Reed National Military Medical Center

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06387329·Phase 4·Recruiting·Listed Apr 2024

Apply to this trial

Global PNH Patient Registry

for Paroxysmal Nocturnal Hemoglobinuria

1 location in Bethesda

Sponsor: Aplastic Anemia and MDS International Foundation

Sex: All·Age: All ages

Code: NCT05755867·Recruiting·Listed Mar 2023

Apply to this trial

An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample

for Stress Disorders, Post-Traumatic

Sites in Bethesda +2 more locations

Sponsor: U.S. Army Medical Research and Development Command

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT04180930·Recruiting·Listed Nov 2019

Apply to this trial

Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome

for Bladder Pain Syndrome

1 location in Bethesda

Sponsor: Walter Reed National Military Medical Center

Sex: Female·Age: 18 - 99·Accepts healthy volunteers

Code: NCT06729151·Recruiting·Listed Dec 2024

Apply to this trial

The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction

for Thyroid Eye Disease

1 location in Bethesda

Sponsor: Walter Reed National Military Medical Center

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06275373·Recruiting·Listed Feb 2024

Apply to this trial

Evaluation of the SafeSpace App Intervention

for Health Behavior

1 location in Bethesda

Sponsor: Child Trends

Sex: Female·Age: 14 - 18·Accepts healthy volunteers

Code: NCT06043596·Recruiting·Listed Sep 2023

Apply to this trial

Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder

for Overactive Bladder

1 location in Bethesda

Sponsor: Walter Reed National Military Medical Center

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT04020510·Phase 4·Recruiting·Listed Jul 2019

Apply to this trial

A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease

for Primary Membranous Nephropathy

Sites in Bethesda +5 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 75

Code: NCT07571746·Phase 2·Recruiting·Listed May 2026

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)

for Multiple Myeloma

Drug: Belantamab mafodotin

Sites in Bethesda +10 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT07227311·Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

for Prostate Cancer

Drug: Saruparib

Sites in Bethesda, Towson +36 more locations

Sponsor: AstraZeneca

Sex: Male·Age: 18+

Code: NCT06952803·Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

for Carcinoma, Non-Small Cell Lung

Drug: Rilvegostomig

Sites in Bethesda, Silver Spring +37 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06868277·Phase 3·Recruiting·Listed Mar 2025

Apply to this trial

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

for Locally Advanced Head and Neck Squamous Cell Carcinoma

Sites in Bethesda, Hyattsville +44 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT06129864·Phase 3·Recruiting·Listed Nov 2023

Apply to this trial

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

for Chronic Kidney Disease and Hypertension

Drug: Dapagliflozin

Sites in Bethesda +116 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06742723·Phase 3·Recruiting·Listed Dec 2024

Apply to this trial

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

for Untreated Follicular Lymphoma

Drug: Rituximab

Sites in Bethesda, Columbia +51 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT06549595·Phase 3·Recruiting·Listed Aug 2024

Apply to this trial

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for Non-small Cell Lung Cancer

Drug: Rilvegostomig

Sites in Bethesda +62 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06692738·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease

for APOL1-Mediated Kidney Disease

Sites in Bethesda, Potomac +76 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 65

Code: NCT06824987·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

for Breast Cancer, Early Breast Cancer

Drug: Camizestrant

Sites in Bethesda, Annapolis +102 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT05952557·Phase 3·Recruiting·Listed Jul 2023

Apply to this trial

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for Acute Coronary Syndrome

Sites in Bethesda +147 more locations

Sponsor: DalCor Pharmaceuticals

Sex: All·Age: 45+

Code: NCT05918861·Phase 3·Recruiting·Listed Jun 2023

Apply to this trial

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

for Tumor Hyperinsulinism (Tumor HI)

Sites in Bethesda +7 more locations

Sponsor: Rezolute

Sex: All·Age: 18+

Code: NCT06881992·Phase 3·Recruiting·Listed Mar 2025

Apply to this trial

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for Metastatic Non-small Cell Lung Cancer

Drug: Osimertinib

Sites in Bethesda, Baltimore +25 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT06417814·Phase 3·Recruiting·Listed May 2024

Apply to this trial

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

for Arrhythmia

Sites in Bethesda, Takoma Park +83 more locations

Sponsor: Medtronic

Sex: All·Age: All ages

Code: NCT00271180·Recruiting·Listed Dec 2005

Apply to this trial

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

for Non-small Cell Lung Cancer

Drug: Osimertinib

Sites in Bethesda +27 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06350097·Phase 3·Recruiting·Listed Apr 2024

Apply to this trial

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

for Colonic Neoplasms

Drug: Dostarlimab

Sites in Bethesda +26 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT05855200·Phase 3·Recruiting·Listed May 2023

Apply to this trial